Trial of Electrical Versus Pharmacological Cardioversion for RAFF in the ED
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 396 participants.
Also called NCT01891058
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 396 participants
- Registry
-
NCT01891058
-
- Other papers using this trial's data
- Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT01891058. Randomized; single masking; primary purpose treatment. Start 2013-07-18 (actual); primary completion 2018-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trial of Electrical Versus Pharmacological Cardioversion for RAFF in the ED
- Acronym
- RAFF-2
- Condition
- Atrial Fibrillation
- Condition
- Atrial Flutter
- Intervention (Device)
- drug-shock vs shock only
- Lead sponsor
- Ottawa Hospital Research Institute
- Collaborator
- The Ottawa Hospital
Record details
- Record id
cardio:ct-nct01891058- Content hash
4e7afd0bf13e543b31ac4385e8c878a7ca4bcf9d4d6c793ee33b303afb09d166